Cronos Group Executive and Leadership Team

Guibison Henrique, the Chief Executive Officer at Cronos Group, directs the company's overarching strategic vision and operational execution. This leadership role involves guiding global teams to achieve ambitious growth targets within the international cannabinoid market. Henrique's focus centers on optimizing production capabilities and expanding distribution networks across the five continents Cronos Group serves. The Chief Executive Officer ensures alignment between corporate objectives and day-to-day operations, driving innovation in product development and market penetration. By fostering a culture of excellence, Henrique oversees the integration of new technologies and market opportunities, solidifying Cronos Group's position as a global leader. This executive's mandate includes navigating complex regulatory landscapes and ensuring sustainable business practices worldwide. Guibison Henrique's strategic direction is paramount to the company's continued success and expansion.

Héctor Chacón Pérez, the Chief Executive Officer & Founder at Cronos Group, establishes the foundational principles and long-term direction for the organization. As Founder, Chacón Pérez imbues the company with its core innovative spirit, driving its mission to lead the global cannabinoid industry. This executive role encompasses setting strategic priorities, identifying emerging market opportunities, and fostering key international partnerships. Chacón Pérez oversees the company's global operations, ensuring that production and distribution across five continents align with the founding vision. The Chief Executive Officer & Founder champions the development of cutting-edge cannabinoid products and cultivates a forward-thinking corporate culture. Héctor Chacón Pérez's leadership is critical in navigating the dynamic international market, ensuring Cronos Group remains at the forefront of innovation and operational excellence. This executive's influence extends to shaping the company's global footprint and market impact.

Michael Gorenstein, the Chairman, President and Chief Executive Officer at Cronos Group, orchestrates the company's highest-level strategic initiatives and corporate governance. This multifaceted leadership position involves guiding the Board of Directors and executive team to achieve sustainable growth and market dominance in the global cannabinoid sector. Gorenstein's responsibilities include overseeing financial performance, driving operational efficiencies across international production and distribution, and ensuring robust corporate strategy. The Chairman, President and Chief Executive Officer champions innovation, directing resources towards the development of advanced cannabinoid products and technologies. Michael Gorenstein's oversight ensures that Cronos Group's operations on five continents adhere to the highest standards of quality and regulatory compliance. This executive's vision is instrumental in shaping the company's long-term trajectory and maximizing shareholder value. Gorenstein's leadership solidifies Cronos Group's international presence and market influence.

Anna Shlimak, the Chief Financial Officer at Cronos Group, directs all financial planning, management, and reporting activities for the global organization. This executive role is critical in managing the financial health and strategic resource allocation across Cronos Group's international operations spanning five continents. Shlimak oversees budgeting, forecasting, treasury, and investor relations, ensuring fiscal discipline and driving profitability. The Chief Financial Officer plays a key part in evaluating investment opportunities and managing financial risks associated with global expansion and product development. Anna Shlimak's expertise is vital in navigating complex international financial regulations and optimizing capital structure to support the company's growth objectives. This leadership position ensures financial transparency and accountability, underpinning the company's commitment to sustainable business practices. Shlimak's strategic financial guidance is essential for Cronos Group's continued success in the dynamic cannabinoid market.

Robert Madore, the Executive Vice President & Chief Financial Officer at Cronos Group, provides critical financial leadership and strategic oversight for the global enterprise. This executive role involves managing complex financial operations, including accounting, financial planning, and analysis, across Cronos Group's international presence on five continents. Madore collaborates closely with the Chief Executive Officer and other senior leaders to develop and execute financial strategies that support long-term growth and profitability. The Executive Vice President & Chief Financial Officer is responsible for ensuring robust financial controls, optimizing capital allocation, and enhancing shareholder value. Robert Madore's expertise is vital in navigating the financial intricacies of the global cannabinoid market and driving operational efficiencies. This leadership position ensures financial integrity and supports strategic decision-making across all business units. Madore's financial acumen is indispensable to Cronos Group's sustained international success.

Mike Kroslak, the Chief Operating Officer at Cronos Group, oversees the company's extensive global operational infrastructure and day-to-day business activities. This executive role is central to ensuring efficient production and seamless distribution of cannabinoid products across the five continents Cronos Group serves. Kroslak directs supply chain management, manufacturing processes, and operational scaling to meet increasing market demand. The Chief Operating Officer focuses on optimizing resource utilization, implementing best practices, and driving operational excellence throughout the organization. Mike Kroslak's leadership ensures that all operational facets align with the company's strategic goals for innovation and market expansion. This position is critical for maintaining high standards of quality and compliance in all global facilities. Kroslak's operational acumen is fundamental to Cronos Group's ability to execute its international business strategy effectively and maintain its competitive edge.

Dinor Levi, the Co-founder & Chief Operating Officer at Cronos Group, plays a pivotal role in shaping and executing the company's operational strategy and global expansion. As Co-founder, Levi brings a deep understanding of the company's origins and vision, driving operational excellence across international production and distribution networks spanning five continents. This executive role involves overseeing key operational functions, including manufacturing, supply chain logistics, and quality assurance, to ensure seamless delivery of cannabinoid products. Dinor Levi focuses on enhancing operational efficiency, implementing innovative processes, and managing resources effectively to meet market demands. The Co-founder & Chief Operating Officer is instrumental in fostering a culture of continuous improvement and driving strategic initiatives that support Cronos Group's global market leadership. Levi's operational leadership is crucial for maintaining high product standards and achieving ambitious growth objectives worldwide.